| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 63.86 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 63.86. The average price that CVS shares were previous bought at was USD 62.9223. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in CVS has increased by USD 166,109 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-06-09 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | SELL | -75 @ USD 137.78 | USD -10,334 | The ETF sold 75 shares of DVA on 2025-06-09. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -10.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,243 The average price that the ETF previously sold DVA share for is USD 153.27 which is higher than the selling price of USD 137.78 on 2025-06-09. |
| CRL - Creightons Plc | SELL | -84 @ USD 147.46 | USD -12,387 | The ETF sold 84 shares of CRL on 2025-06-09. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -12.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,745 The average price that the ETF previously sold CRL share for is USD 187.684 which is higher than the selling price of USD 147.46 on 2025-06-09. |
| TECH - Bio-Techne Corp | SELL | -261 @ USD 49.88 | USD -13,019 | The ETF sold 261 shares of TECH on 2025-06-09. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -23.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,948 The average price that the ETF previously sold TECH share for is USD 70.1345 which is higher than the selling price of USD 49.88 on 2025-06-09. |
| HSIC - Henry Schein Inc | SELL | -207 @ USD 70.9 | USD -14,676 | The ETF sold 207 shares of HSIC on 2025-06-09. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 400 The average price that the ETF previously sold HSIC share for is USD 71.1244 which is higher than the selling price of USD 70.9 on 2025-06-09. |
| MRNA - Moderna Inc | SELL | -552 @ USD 28.14 | USD -15,533 | The ETF sold 552 shares of MRNA on 2025-06-09. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -20.5% lower than average price of previous purchases. This resulted in an overall loss of USD 4,003 The average price that the ETF previously sold MRNA share for is USD 41.2803 which is higher than the selling price of USD 28.14 on 2025-06-09. |
| UHS - Universal Health Services Inc | SELL | -93 @ USD 177.77 | USD -16,533 | The ETF sold 93 shares of UHS on 2025-06-09. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,051 The average price that the ETF previously sold UHS share for is USD 192.697 which is higher than the selling price of USD 177.77 on 2025-06-09. |
| SOLV - Solventum Corp. | SELL | -222 @ USD 74.92 | USD -16,632 | The ETF sold 222 shares of SOLV on 2025-06-09. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for 1.0% higher than average price of previous purchases. This sale made a profit of USD 172 The average price that the ETF previously sold SOLV share for is USD 70.3143 so the ETF has sold 222 shares on 2025-06-09 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -2,004 @ USD 8.81 | USD -17,655 | The ETF sold 2004 shares of VTRS on 2025-06-09. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -15.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,183 The average price that the ETF previously sold VTRS share for is USD 12.065 which is higher than the selling price of USD 8.81 on 2025-06-09. |
| INCY - Incyte Corporation | SELL | -267 @ USD 69.89 | USD -18,661 | The ETF sold 267 shares of INCY on 2025-06-09. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 236 The average price that the ETF previously sold INCY share for is USD 72.3259 which is higher than the selling price of USD 69.89 on 2025-06-09. |
| RVTY - Revvity Inc. | SELL | -204 @ USD 92.88 | USD -18,948 | The ETF sold 204 shares of RVTY on 2025-06-09. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,896 The average price that the ETF previously sold RVTY share for is USD 113.366 which is higher than the selling price of USD 92.88 on 2025-06-09. |
| ALGN - Align Technology Inc | SELL | -117 @ USD 180.93 | USD -21,169 | The ETF sold 117 shares of ALGN on 2025-06-09. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -3.9% lower than average price of previous purchases. This resulted in an overall loss of USD 859 The average price that the ETF previously sold ALGN share for is USD 214.429 which is higher than the selling price of USD 180.93 on 2025-06-09. |
| HOLX - Hologic Inc | SELL | -372 @ USD 64.57 | USD -24,020 | The ETF sold 372 shares of HOLX on 2025-06-09. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 867 The average price that the ETF previously sold HOLX share for is USD 71.8805 which is higher than the selling price of USD 64.57 on 2025-06-09. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -336 @ USD 71.97 | USD -24,182 | The ETF sold 336 shares of COO on 2025-06-09. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -19.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,752 The average price that the ETF previously sold COO share for is USD 95.6912 which is higher than the selling price of USD 71.97 on 2025-06-09. |
| BAX - Baxter International Inc | SELL | -840 @ USD 30.85 | USD -25,914 | The ETF sold 840 shares of BAX on 2025-06-09. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,075 The average price that the ETF previously sold BAX share for is USD 32.396 which is higher than the selling price of USD 30.85 on 2025-06-09. |
| WST - West Pharmaceutical Services Inc | SELL | -117 @ USD 223.77 | USD -26,181 | The ETF sold 117 shares of WST on 2025-06-09. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,806 The average price that the ETF previously sold WST share for is USD 302.223 which is higher than the selling price of USD 223.77 on 2025-06-09. |
| MOH - MOH | SELL | -90 @ USD 297 | USD -26,730 | The ETF sold 90 shares of MOH on 2025-06-09. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,123 The average price that the ETF previously sold MOH share for is USD 306.769 which is higher than the selling price of USD 297 on 2025-06-09. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -90 @ USD 297 | USD -26,730 | The ETF sold 90 shares of MOH on 2025-06-09. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -4.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,123 The average price that the ETF previously sold MOH share for is USD 306.769 which is higher than the selling price of USD 297 on 2025-06-09. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -327 @ USD 92.83 | USD -30,355 | The ETF sold 327 shares of ZBH on 2025-06-09. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,667 The average price that the ETF previously sold ZBH share for is USD 107.06 which is higher than the selling price of USD 92.83 on 2025-06-09. |
| BIIB - Biogen Inc | SELL | -240 @ USD 134.15 | USD -32,196 | The ETF sold 240 shares of BIIB on 2025-06-09. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -7.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,758 The average price that the ETF previously sold BIIB share for is USD 156.971 which is higher than the selling price of USD 134.15 on 2025-06-09. |
| DGX - Quest Diagnostics Incorporated | SELL | -186 @ USD 175.9 | USD -32,717 | The ETF sold 186 shares of DGX on 2025-06-09. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 1,653 The average price that the ETF previously sold DGX share for is USD 159.912 so the ETF has sold 186 shares on 2025-06-09 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -96 @ USD 348.33 | USD -33,440 | The ETF sold 96 shares of WAT on 2025-06-09. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,009 The average price that the ETF previously sold WAT share for is USD 371.938 which is higher than the selling price of USD 348.33 on 2025-06-09. |
| WAT - MULETFWATIMETFP | SELL | -96 @ USD 348.33 | USD -33,440 | The ETF sold 96 shares of WAT on 2025-06-09. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,009 The average price that the ETF previously sold WAT share for is USD 371.938 which is higher than the selling price of USD 348.33 on 2025-06-09. |
| LH - Laboratory Corporation of America Holdings | SELL | -135 @ USD 255.73 | USD -34,524 | The ETF sold 135 shares of LH on 2025-06-09. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 1,950 The average price that the ETF previously sold LH share for is USD 236.262 so the ETF has sold 135 shares on 2025-06-09 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -114 @ USD 305.66 | USD -34,845 | The ETF sold 114 shares of PODD on 2025-06-09. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 14.0% higher than average price of previous purchases. This sale made a profit of USD 4,272 The average price that the ETF previously sold PODD share for is USD 264.154 so the ETF has sold 114 shares on 2025-06-09 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -33 @ USD 1195.39 | USD -39,448 | The ETF sold 33 shares of MTD on 2025-06-09. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,452 The average price that the ETF previously sold MTD share for is USD 1237.05 which is higher than the selling price of USD 1195.39 on 2025-06-09. |
| MTD - AMUNDI EUR GOV 710 | SELL | -33 @ USD 1195.39 | USD -39,448 | The ETF sold 33 shares of MTD on 2025-06-09. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 1,452 The average price that the ETF previously sold MTD share for is USD 1237.05 which is higher than the selling price of USD 1195.39 on 2025-06-09. |
| STE - STERIS plc | SELL | -165 @ USD 242.7 | USD -40,046 | The ETF sold 165 shares of STE on 2025-06-09. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 3,401 The average price that the ETF previously sold STE share for is USD 216.086 so the ETF has sold 165 shares on 2025-06-09 at a higher price than the previous selling average. |
| IQV - IQVIA Holdings Inc | SELL | -276 @ USD 154.15 | USD -42,545 | The ETF sold 276 shares of IQV on 2025-06-09. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -19.6% lower than average price of previous purchases. This resulted in an overall loss of USD 10,341 The average price that the ETF previously sold IQV share for is USD 196.081 which is higher than the selling price of USD 154.15 on 2025-06-09. |
| HUM - Hummingbird Resources PLC | SELL | -198 @ USD 233.07 | USD -46,148 | The ETF sold 198 shares of HUM on 2025-06-09. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,320 The average price that the ETF previously sold HUM share for is USD 276.366 which is higher than the selling price of USD 233.07 on 2025-06-09. |
| HUM - Humana Inc | SELL | -198 @ USD 233.07 | USD -46,148 | The ETF sold 198 shares of HUM on 2025-06-09. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,320 The average price that the ETF previously sold HUM share for is USD 276.366 which is higher than the selling price of USD 233.07 on 2025-06-09. |
| CNC - Concurrent Technologies Plc | SELL | -828 @ USD 55.76 | USD -46,169 | The ETF sold 828 shares of CNC on 2025-06-09. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for -7.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,609 The average price that the ETF previously sold CNC share for is USD 60.0838 which is higher than the selling price of USD 55.76 on 2025-06-09. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -753 @ USD 71.67 | USD -53,968 | The ETF sold 753 shares of GEHC on 2025-06-09. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -15.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,913 The average price that the ETF previously sold GEHC share for is USD 80.9889 which is higher than the selling price of USD 71.67 on 2025-06-09. |
| A - Agilent Technologies Inc | SELL | -471 @ USD 116.74 | USD -54,985 | The ETF sold 471 shares of A on 2025-06-09. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -9.4% lower than average price of previous purchases. This resulted in an overall loss of USD 5,733 The average price that the ETF previously sold A share for is USD 132.067 which is higher than the selling price of USD 116.74 on 2025-06-09. |
| DXCM - DexCom Inc | SELL | -651 @ USD 85.68 | USD -55,778 | The ETF sold 651 shares of DXCM on 2025-06-09. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 5,075 The average price that the ETF previously sold DXCM share for is USD 75.819 so the ETF has sold 651 shares on 2025-06-09 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -243 @ USD 250.98 | USD -60,988 | The ETF sold 243 shares of RMD on 2025-06-09. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 4,073 The average price that the ETF previously sold RMD share for is USD 240.194 so the ETF has sold 243 shares on 2025-06-09 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -402 @ USD 153.62 | USD -61,755 | The ETF sold 402 shares of CAH on 2025-06-09. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 19.7% higher than average price of previous purchases. This sale made a profit of USD 10,166 The average price that the ETF previously sold CAH share for is USD 123.146 so the ETF has sold 402 shares on 2025-06-09 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -132 @ USD 518.6 | USD -68,455 | The ETF sold 132 shares of IDXX on 2025-06-09. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 17.6% higher than average price of previous purchases. This sale made a profit of USD 10,269 The average price that the ETF previously sold IDXX share for is USD 429.398 so the ETF has sold 132 shares on 2025-06-09 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -978 @ USD 76.36 | USD -74,680 | The ETF sold 978 shares of EW on 2025-06-09. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 7.1% higher than average price of previous purchases. This sale made a profit of USD 4,969 The average price that the ETF previously sold EW share for is USD 70.481 so the ETF has sold 978 shares on 2025-06-09 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -285 @ USD 283.95 | USD -80,926 | The ETF sold 285 shares of COR on 2025-06-09. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 11.5% higher than average price of previous purchases. This sale made a profit of USD 8,352 The average price that the ETF previously sold COR share for is USD 247.17 so the ETF has sold 285 shares on 2025-06-09 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -477 @ USD 172.51 | USD -82,287 | The ETF sold 477 shares of BDX on 2025-06-09. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -23.9% lower than average price of previous purchases. This resulted in an overall loss of USD 25,795 The average price that the ETF previously sold BDX share for is USD 222.535 which is higher than the selling price of USD 172.51 on 2025-06-09. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -174 @ USD 517.6 | USD -90,062 | The ETF sold 174 shares of REGN on 2025-06-09. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -26.5% lower than average price of previous purchases. This resulted in an overall loss of USD 32,522 The average price that the ETF previously sold REGN share for is USD 745.729 which is higher than the selling price of USD 517.6 on 2025-06-09. |
| HCA - HCA Holdings Inc | SELL | -294 @ USD 373.01 | USD -109,665 | The ETF sold 294 shares of HCA on 2025-06-09. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 10,296 The average price that the ETF previously sold HCA share for is USD 328.252 so the ETF has sold 294 shares on 2025-06-09 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -741 @ USD 164.61 | USD -121,976 | The ETF sold 741 shares of ZTS on 2025-06-09. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -1.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,933 The average price that the ETF previously sold ZTS share for is USD 171.37 which is higher than the selling price of USD 164.61 on 2025-06-09. |
| CI - Cigna Corp | SELL | -453 @ USD 311.4 | USD -141,064 | The ETF sold 453 shares of CI on 2025-06-09. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,431 The average price that the ETF previously sold CI share for is USD 312.884 which is higher than the selling price of USD 311.4 on 2025-06-09. |
| MCK - McKesson Corporation | SELL | -207 @ USD 708.22 | USD -146,602 | The ETF sold 207 shares of MCK on 2025-06-09. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 13.9% higher than average price of previous purchases. This sale made a profit of USD 17,935 The average price that the ETF previously sold MCK share for is USD 604.495 so the ETF has sold 207 shares on 2025-06-09 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -381 @ USD 389.61 | USD -148,441 | The ETF sold 381 shares of ELV on 2025-06-09. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,054 The average price that the ETF previously sold ELV share for is USD 401.888 which is higher than the selling price of USD 389.61 on 2025-06-09. |
| ELV - Elevance Health Inc | SELL | -381 @ USD 389.61 | USD -148,441 | The ETF sold 381 shares of ELV on 2025-06-09. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -5.1% lower than average price of previous purchases. This resulted in an overall loss of USD 8,054 The average price that the ETF previously sold ELV share for is USD 401.888 which is higher than the selling price of USD 389.61 on 2025-06-09. |
| BMY - Bloomsbury Publishing Plc | SELL | -3,369 @ USD 49 | USD -165,081 | The ETF sold 3369 shares of BMY on 2025-06-09. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -14.5% lower than average price of previous purchases. This resulted in an overall loss of USD 28,012 The average price that the ETF previously sold BMY share for is USD 56.2625 which is higher than the selling price of USD 49 on 2025-06-09. |
| MDT - Medtronic PLC | SELL | -2,124 @ USD 87.45 | USD -185,744 | The ETF sold 2124 shares of MDT on 2025-06-09. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -1.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,754 The average price that the ETF previously sold MDT share for is USD 85.3881 so the ETF has sold 2124 shares on 2025-06-09 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -423 @ USD 446.15 | USD -188,721 | The ETF sold 423 shares of VRTX on 2025-06-09. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -6.8% lower than average price of previous purchases. This resulted in an overall loss of USD 13,748 The average price that the ETF previously sold VRTX share for is USD 463.183 which is higher than the selling price of USD 446.15 on 2025-06-09. |
| DHR - Danaher Corporation | SELL | -1,059 @ USD 199.2 | USD -210,953 | The ETF sold 1059 shares of DHR on 2025-06-09. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 18,513 The average price that the ETF previously sold DHR share for is USD 230.46 which is higher than the selling price of USD 199.2 on 2025-06-09. |
| DHR - Danaher Corporation | SELL | -1,059 @ USD 199.2 | USD -210,953 | The ETF sold 1059 shares of DHR on 2025-06-09. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -8.1% lower than average price of previous purchases. This resulted in an overall loss of USD 18,513 The average price that the ETF previously sold DHR share for is USD 230.46 which is higher than the selling price of USD 199.2 on 2025-06-09. |
| SYK - Stryker Corporation | SELL | -567 @ USD 382.28 | USD -216,753 | The ETF sold 567 shares of SYK on 2025-06-09. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 1,446 The average price that the ETF previously sold SYK share for is USD 375.165 so the ETF has sold 567 shares on 2025-06-09 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -9,399 @ USD 23.97 | USD -225,294 | The ETF sold 9399 shares of PFE on 2025-06-09. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 17,262 The average price that the ETF previously sold PFE share for is USD 25.8653 which is higher than the selling price of USD 23.97 on 2025-06-09. |
| GILD - Guild Esports Plc | SELL | -2,067 @ USD 113 | USD -233,571 | The ETF sold 2067 shares of GILD on 2025-06-09. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 20,689 The average price that the ETF previously sold GILD share for is USD 94.6779 so the ETF has sold 2067 shares on 2025-06-09 at a higher price than the previous selling average. |
| BSX - Boston Scientific Corporation | SELL | -2,442 @ USD 100.04 | USD -244,298 | The ETF sold 2442 shares of BSX on 2025-06-09. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 3,309 The average price that the ETF previously sold BSX share for is USD 90.8476 so the ETF has sold 2442 shares on 2025-06-09 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -2,442 @ USD 100.04 | USD -244,298 | The ETF sold 2442 shares of BSX on 2025-06-09. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 3,309 The average price that the ETF previously sold BSX share for is USD 90.8476 so the ETF has sold 2442 shares on 2025-06-09 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -888 @ USD 289.98 | USD -257,502 | The ETF sold 888 shares of AMGN on 2025-06-09. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 11,757 The average price that the ETF previously sold AMGN share for is USD 288.798 so the ETF has sold 888 shares on 2025-06-09 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -633 @ USD 408.53 | USD -258,599 | The ETF sold 633 shares of TMO on 2025-06-09. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -21.7% lower than average price of previous purchases. This resulted in an overall loss of USD 71,669 The average price that the ETF previously sold TMO share for is USD 519.222 which is higher than the selling price of USD 408.53 on 2025-06-09. |
| ISRG - Intuitive Surgical Inc | SELL | -588 @ USD 526.15 | USD -309,376 | The ETF sold 588 shares of ISRG on 2025-06-09. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 8,791 The average price that the ETF previously sold ISRG share for is USD 531.33 which is higher than the selling price of USD 526.15 on 2025-06-09. |
| MRK - Marks Electrical Group PLC | SELL | -4,197 @ USD 79.33 | USD -332,948 | The ETF sold 4197 shares of MRK on 2025-06-09. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 52,635 The average price that the ETF previously sold MRK share for is USD 98.0825 which is higher than the selling price of USD 79.33 on 2025-06-09. |
| MRK - Merck & Company Inc | SELL | -4,197 @ USD 79.33 | USD -332,948 | The ETF sold 4197 shares of MRK on 2025-06-09. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -13.7% lower than average price of previous purchases. This resulted in an overall loss of USD 52,635 The average price that the ETF previously sold MRK share for is USD 98.0825 which is higher than the selling price of USD 79.33 on 2025-06-09. |
| ABT - Abbott Laboratories | SELL | -2,877 @ USD 133.4 | USD -383,792 | The ETF sold 2877 shares of ABT on 2025-06-09. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 18,315 The average price that the ETF previously sold ABT share for is USD 118.141 so the ETF has sold 2877 shares on 2025-06-09 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,521 @ USD 303.19 | USD -461,152 | The ETF sold 1521 shares of UNH on 2025-06-09. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -42.2% lower than average price of previous purchases. This resulted in an overall loss of USD 336,059 The average price that the ETF previously sold UNH share for is USD 550.669 which is higher than the selling price of USD 303.19 on 2025-06-09. |
| ABBV - AbbVie Inc | SELL | -2,913 @ USD 189.16 | USD -551,023 | The ETF sold 2913 shares of ABBV on 2025-06-09. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 12,806 The average price that the ETF previously sold ABBV share for is USD 185.034 so the ETF has sold 2913 shares on 2025-06-09 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -3,969 @ USD 155.23 | USD -616,108 | The ETF sold 3969 shares of JNJ on 2025-06-09. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 10,911 The average price that the ETF previously sold JNJ share for is USD 152.578 so the ETF has sold 3969 shares on 2025-06-09 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -1,290 @ USD 773.71 | USD -998,086 | The ETF sold 1290 shares of LLY on 2025-06-09. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -7.6% lower than average price of previous purchases. This resulted in an overall loss of USD 82,477 The average price that the ETF previously sold LLY share for is USD 793.171 which is higher than the selling price of USD 773.71 on 2025-06-09. |